FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
   2. Issuer Name and Ticker or Trading Symbol
NATURES SUNSHINE PRODUCTS INC [NATR] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
BUILDING A, NO. 1289, YISHAN ROAD		 3. Date of Earliest Transaction (Month/Day/Year)
04/12/2021
(Street)

SHANGHAI, F4 200233		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/12/2021   J   711 (1) A $ 0 39,836 I by Fosun Industrial Co., Limited (2)
Common Stock 01/07/2022   J   9,558 (3) A $ 0 49,394 I by Fosun Industrial Co., Limited (2)
Common Stock 01/21/2022   J   25,000 (4) A $ 8.72 (5) 74,394 I by Fosun Industrial Co., Limited (2)
Common Stock               2,854,607 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
BUILDING A, NO. 1289
YISHAN ROAD
SHANGHAI, F4 200233		     X    

Signatures

 Shanghai Fosun Pharmaceutical (Group) Co., Ltd., By: /s/ WU Yifang/Chairman   01/24/2022
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These shares represent incremental shares granted by the Issuer as an adjustment to the vested option award of a former director of the Issuer (the "Former Director"). These shares initially reported on a Form 4 filed by the Former Director, but were actually issued to Fosun Industrial Co., Limited. Due to this oversight, a Form 4 was not previously filed by the Reporting Person regarding this issuance.
(2) Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person.
(3) These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the delivery of certain vested restricted stock units that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person.
(4) These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the exercise of certain stock options (the "Options") that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person.
(5) Represents the exercise price paid by Fosun Industrial Co., Limited for the shares underlying the Options upon the exercise of the Options.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.